52 VANDERBILT AVENUE, NEW YORK, NY, UNITED STATES, 10017
国家
美国
上市日期
2026-04-15
财年截止
十二月
流通股数
2747万
CIK
--
官方网址
--
NewHold Investment Corp IV (NHIV) 是一家特殊目的收购公司(SPAC),专注于识别并与主要处于科技和医疗保健行业的高增长企业合并。凭借其资本和行业专长,NHIV 旨在促进具有显著增长潜力的创新公司的发展。该公司致力于通过战略合作伙伴关系创造价值,同时将自身定位于把握新兴市场趋势。NewHold Investment Corp IV 由一支在运营管理和投资方面拥有丰富经验的专业人士团队领导,具备推动成功合并并为投资者带来可观回报的能力。
财务指标
营业收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
营业支出
2026-06-30
$61.9万
2026-03-31
$3.8万
2025-12-31
$4.7万
净利润
2026-06-30
$85.4万
2026-03-31
-$3.8万
2025-12-31
-$4.7万
净利润率
2026-06-30
--
2026-03-31
--
2025-12-31
--
每股收益
2026-06-30
$0.03
2026-03-31
--
2025-12-31
--
息税折旧摊销前利润
2026-06-30
-$61.9万
2026-03-31
-$3.8万
2025-12-31
-$4.7万
有效税率
2026-06-30
--
2026-03-31
--
2025-12-31
--
项目
2026-06-30
2026-03-31
2025-12-31
营业收入
$0
$0
$0
营业支出
$61.9万
$3.8万
$4.7万
净利润
$85.4万
-$3.8万
-$4.7万
净利润率
--
--
--
每股收益
$0.03
--
--
息税折旧摊销前利润
-$61.9万
-$3.8万
-$4.7万
有效税率
--
--
--
常见问题
NHIV is a U.S.-listed stock ticker representing shares of a publicly traded company. The specific business operations, sector, and listing exchange for NHIV are detailed on the stock's profile page, which displays the latest company description. Investors can review that page to confirm the company's legal name, headquarters, and primary activities before researching further.
Recent performance for NHIV is shown through current and historical price data on the stock detail page, including daily changes and longer-term trends. Because prices move continuously during market hours, the most accurate recent performance figures are those displayed there. Reviewing that data alongside volume and broader market conditions can help put NHIV's recent moves into context.
Evaluating NHIV's valuation typically involves comparing its market price against fundamental metrics such as earnings, book value, and revenue, using ratios like P/E or price-to-sales. These figures for NHIV are available on the stock detail page and in its financial statements. Comparing those metrics with peer companies and the broader market can help investors assess whether NHIV appears relatively expensive or inexpensive.
NHIV may trade in pre-market and after-hours sessions through certain brokers, though liquidity outside regular U.S. market hours is often thinner and spreads can be wider. Not all brokers support extended-hours trading for every stock, so availability for NHIV depends on the platform. The stock detail page shows the latest price data, which may reflect extended-hours activity where applicable.
Analyzing NHIV's financial performance generally starts with its quarterly and annual reports, including the income statement, balance sheet, and cash flow statement. Key items to review include revenue growth, margins, net income, and cash generation. The stock detail page and SEC filings provide these figures for NHIV, allowing investors to compare results across periods and against industry peers.
Risks for NHIV depend on its specific business, but common factors include industry competition, revenue concentration, debt levels, and sensitivity to economic cycles. Market-wide risks such as interest rate changes and investor sentiment can also affect the share price. NHIV's SEC filings, particularly the risk factors section, outline company-specific risks that investors should review before making any decisions.